FGFBP2 antibody (C-Term)

Catalog No. ABIN926544

Product Details anti-FGFBP2 Antibody

Target: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Binding Specificity: C-Term

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This FGFBP2 antibody is un-conjugated

Application: Western Blotting (WB)

Purification: Purified

Immunogen: FGFBP2 antibody was raised in rabbit using the C terminal of FGFBP2 as the immunogen

Application Details

Application Notes: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

FGFBP2 Blocking Peptide, catalog no. 33R-4979, is also available for use as a blocking control in assays to test for specificity of this FGFBP2 antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for FGFBP2

Target: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Alternative Name: FGFBP2 (FGFBP2 Products)

Synonyms: fb08g06 antibody, wu:fb08g06 antibody, HBP17RP antibody, KSP37 antibody, fibroblast growth factor binding protein 2 antibody, fibroblast growth factor binding protein 2a antibody, fibroblast growth factor binding protein 2 L homeolog antibody, FGFBP2 antibody, fgfbp2a antibody, fgfbp2.L antibody

Background: FGFBP2 is a member of the fibroblast growth factor binding protein family. The encoded protein is a serum protein that is selectively secreted by cytotoxic lymphocytes and may be involved in cytotoxic lymphocyte-mediated immunity. An increase in the amount of gene product may be associated with atopic asthma and mild extrinsic asthma. Synonyms: Polyclonal FGFBP2 antibody, Anti-FGFBP2 antibody, fibroblast growth factor binding protein 2 antibody, HBP17RP antibody, KSP37 antibody.